Healthcare -
Biotechnology - NASDAQ - US
$ 6.17
6.56 %
$ 192 M
Market Cap
-2.32
P/E
ACRV - CAPITAL EXPENDITURES
Capital Expenditures ACRV - Acrivon Therapeutics, Inc. Common Stock
-1.29 M
LAST VALUE
-132.63%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR